Skip to main content
SpringerLink
Log in

Pertussis vaccines

  • Chapter
Recent Developments in Prophylactic Immunization

Part of the book series: Immunology and Medicine ((IMME,volume 12))

  • 44 Accesses

Abstract

Whooping cough (pertussis) is a serious disease of infancy, and although mortality due to the disease is now relatively low in developed countries, perhaps 1 million children die from this infection per year worldwide1. Improvements in living conditions and standards of hygiene have contributed greatly to reducing the incidence of the infection but effective vaccination has also had a marked effect and a continuing high level of vaccination has been shown to be necessary to prevent recrudescence of the disease in the population. Provided physicians are alert to the possibility of adult pertussis infection, the disease is found in adults2,3.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Muller, A. S., Leeuwenburg, J. and Pratt, D. S. (1986). Pertussis epidemiology and control. Bull. WHO, 64, 321–31

    PubMed  CAS  Google Scholar 

  2. Thomas, M. G., Ashworth, L. A. E., Miller, E. and Lambert, H. P. (1988). Serum IgG, IgA and IgM responses to pertussis toxin, filamentous haemagglutinin and agglutinogens 2 and 3 following Bordetella pertussis infection. (Submitted for publication)

    Google Scholar 

  3. Trollfors, B. and Rabo, E. (1981) Whooping cough in adults. Br. Med. J., 283, 696–7

    Article  CAS  Google Scholar 

  4. Fine, P. E. M. and Clarkson, J. A. (1987) Reflections on the efficacy of pertussis vaccines. Rev. Infect. Dis., 9, 866–83

    Article  PubMed  CAS  Google Scholar 

  5. Jenkinson, D. (1988). Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br. Med. J., 296, 612–14

    Article  CAS  Google Scholar 

  6. Winsnes, R. (1988) Serological responses to pertussis. In Wardlaw, A. C. and Parton, R. (eds) Pathogenesis and Immunity in Pertussis, pp. 283–307. (Chichester: John Wiley & Sons)

    Google Scholar 

  7. Robinson, A., Irons, L. I. and Ashworth, L. A. E. (1985). Pertussis vaccine: present status and future prospects. Vaccine, 3, 11–22

    Article  PubMed  CAS  Google Scholar 

  8. Robinson, A. and Ashworth, L. A. E. (1988). Acellular and defined-component vaccines against pertussis. In Wardlaw, A. C. and Parton, R. (eds), Pathogenesis and Immunity in Pertussis, pp. 399–417. (Chichester: John Wiley & Sons)

    Google Scholar 

  9. Wardlaw, A. C. and Parton, R. (1988). The host-parasite relationship in pertussis. In Wardlaw, A. C. and Parton, R. (eds), Pathogenesis and Immunity in Pertussis, pp. 327–52. (Chichester: John Wiley & Sons)

    Google Scholar 

  10. Weiss, A. A. and Hewlett, E. L. (1986). Virulence factors of Bordetella pertussis. Ann. Rev. Microbiol., 40, 661–86

    Article  CAS  Google Scholar 

  11. Tuomanen, E. (1988). Bordetella pertussis adhesins. In Wardlaw, A. C. and Parton, R. (eds), Pathogenesis and Immunity in Pertussis, pp. 75–94. (Chichester: John Wiley & Sons)

    Google Scholar 

  12. Robinson, A. and Irons, L. I. (1983). Synergistic effects of Bordetella pertussis lymphocytosis promoting factor on protective activities of Bordetella antigens in mice. Infect. Immun., 40, 523–48

    PubMed  CAS  Google Scholar 

  13. Ashworth, L. A. E., Irons, L. I. and Dowsett, A. B. (1982). The antigenic relationship between serotype specific agglutinogens and fimbriae of Bordetella pertussis. Infect. Immun., 37, 1278–81

    PubMed  CAS  Google Scholar 

  14. Ashworth, L. A. E., Dowsett, A. B., Irons, L. I. and Robinson, A. (1985). The location of surface antigens of Bordetella pertussis by immuno-electron microscopy. In Proceedings of Fourth International Symposium on Pertussis. Develop. Biol. Standard, 61, 143–51

    Google Scholar 

  15. Irons, L. I., Ashworth, L. A. E. and Robinson, A. (1985). Release and purification of fimbriae from Bordetella pertussis. In Proceedings of Fourth International Symposium on Pertussis, Dev. Biol. Stand., 61, 153–63

    Google Scholar 

  16. Zhang, J. M., Cowell, J. L., Steven, A. C., Carter, P. H., McGrath, P. P. and Manclark, C. R. (1985). Purification and characterization of fimbriae isolated from Bordetella pertussis. Infect. Immun., 48, 422–7

    CAS  Google Scholar 

  17. Zhang, J. M., Cowell, J. L., Steven, A. C. and Manclark, C. R. (1985). Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen. In Proceedings of Fourth International Symposium on Pertussis. Dev. Biol. Stand., 61, 173–85

    Google Scholar 

  18. Mooi, F. R., van der Herde, H. G. J., ter Avest, A. R., Welinder, K. G., Livey, I., van der Zeijst, B. A. M. J. and Gaastra, W. (1987). Characterisation of fimbrial subunits from Bordetella species. Microb. Pathogen., 2, 473

    Article  CAS  Google Scholar 

  19. Li, Z. M., Cowell, J. L., Brennan, M. J., Burns, D. L. and Manclark, C. R. (1988). Agglutinating monoclonal antibodies that specifically recognise lipooligosaccharide A of B. pertussis. Infect. Immun., 56, 699–702

    PubMed  CAS  Google Scholar 

  20. Eldering, G., Hornbeck, C. and Baker, J. (1957). Serological study of Bordetella pertussis and related species. J. Bacteriol., 74, 133–6

    Article  PubMed  CAS  Google Scholar 

  21. Livey, I., Duggleby, C. J. and Robinson, A. (1987) Cloning and nucleotide sequence analysis of the serotype 2 fimbrial subunit gene of Bordetella pertussis. Molec. Microbiol., 1, 203–9

    Article  CAS  Google Scholar 

  22. Cowell, J. L., Zhang, J. M., Urisu, A., Suzuki, A., Steven, A. G., Liu, T., Liu, Y. and Manclark, C. R. (1987). Purification and characterisation of serotype 6 fimbrae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae. Infect. Immun., 55, 916–22

    PubMed  CAS  Google Scholar 

  23. MRC (1959). Vaccination against whooping cough — final report. Br. Med. J., 1, 994–1000

    Article  Google Scholar 

  24. Gorringe, A. R., Ashworth, L. A. E., Irons, L. I. and Robinson, A. (1985). Effect of monoclonal antibodies on the adherence of Bordetella pertussis to Vero cells. FEMS. Microbiol Lett., 26, 5–9

    Article  Google Scholar 

  25. Robinson, A., Ashworth, L. A. E., Baskerville, A. and Irons, L. I. (1985). Protection against intranasal infection of mice with Bordetella pertussis. In Proceedings of the Fourth International Symposium on Pertussis. Develop. Biol Standard, 61, 165–72

    Google Scholar 

  26. Preston, N. W. (1988). Pertussis today. In Wardlaw, A. C. and Parton, R. (eds), Pathogenesis and Immunity in Pertussis, pp. 1–18. (Chichester: John Wiley & Sons)

    Google Scholar 

  27. Irons, L. I. and Gorringe, A. A. (1988) Pertussis toxin: production, purification, molecular structure and assay. In Wardlaw, A. C. and Parton, R. (eds), Pathogenesis and Immunity in Pertussis, pp. 95–120. (Chichester: John Wiley & Sons)

    Google Scholar 

  28. Ui, M. (1988). The multiple biological activities of pertussis toxin. In Wardlaw, A. C. and Parton, R. (eds), Pathogenesis and Immunity in Pertussis, pp. 121–45. (Chichester: John Wiley & Sons)

    Google Scholar 

  29. Furman, B. L., Sidey, F. M. and Smith, M. (1988). Metabolic disturbances produced by pertussis toxin. In Wardlaw, A. C. and Parton, R. (eds), Pathogenesis and Immunity in Pertussis, pp. 147–72. (Chichester: John Wiley & Sons)

    Google Scholar 

  30. Sekura, R. D., Schneerson, R. and Robbins, J. B. (1986). Safety and antigenicity of a pertussis toxoid vaccine evaluated in adult volunteers. In Workshop on Acellular Pertussis Vaccines; sponsored by the Interagency Group to Monitor Vaccine Development, Production and Usage, US Department of Health and Human Services and US Public Health Service, Bethesda. September, pp. 135–8

    Google Scholar 

  31. Christodoulides, M., Sidey, F. M., Parton, R. and Stewart-Tull, D. E. S. (1987). Acellular pertussis vaccine prepared by a simple extraction and toxoiding procedure. Vaccine, 5, 199–207

    Article  PubMed  CAS  Google Scholar 

  32. Sato, H., Ito, A., Chiba, J. and Sato, Y. (1984). Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections. Infect. Immun., 46, 422–8

    PubMed  CAS  Google Scholar 

  33. Sato, H., Sato, Y., Ito, A. and Ohishi, I. (1987). Effect of a monoclonal antibody to pertussis toxin on toxin activity. Infect. Immun., 55, 909–15

    PubMed  CAS  Google Scholar 

  34. Anwar, H., Ashworth, L. A. E., Funnell, S., Robinson, A. and Irons, L. I. (1987). Neutralisation of the biological activities of pertussis toxin with a monoclonal antibody. FEMS Microbiol. Lett., 44, 141–5

    Article  CAS  Google Scholar 

  35. Bartoloni, A., Pizza, M., Bigio, M., Nucci, D., Ashworth, L. A. E., Irons, L. I., Robinson, A., Burns, D., Manclark, C., Sato, H. and Rappuoli, R. (1988). Mapping of a protective epitope of pertussis toxin by in vitro refolding of recombinant fragments. Biotechnology, 6, 709–12

    Article  CAS  Google Scholar 

  36. Runeberg-Nyman, K., Engstrom, O., Lofdahl, S., Ylostalo, S. and Sarvas, M. (1987). Expression and secretion of pertussis toxin subunit S1 in Bacillus subtilis. Microb. Pathogen., 3, 461–8

    Article  CAS  Google Scholar 

  37. Burnette, W. N., Mar, V. L., Cieplak, W., Morric, C. F., Kaljot, K. T., Marchito, K. S., Sachdev, R. K., Locht, C. and Keith, J. M. (1988). Direct expression of Bordetella pertussis toxin subunits to high levels in Escherichia coli. Biotechnology, 6, 699–706

    Article  CAS  Google Scholar 

  38. Nicosia, A., Bartoloni, A., Perugini, M. and Rappuoli, R. (1987). Expression and immunological properties of the five subunits of pertussis toxin. Infect. Immun., 55, 953–67

    Google Scholar 

  39. Arcinega, J. L., Burns, D. L., Garcia-Ortigoza, E. and Manclark, C. R. (1987). Immune response to the B oligomer of pertussis toxin. Infect. Immun., 15, 1132–6

    Google Scholar 

  40. Askelof, P., Rodmalm, K., Abens, J., Unden, A. and Bartfai, T. (1988). Use of synthetic peptides to map antigenic sites of Bordetella pertussis toxin subunit SI. J. Infect Dis., 157, 738–42

    Article  PubMed  CAS  Google Scholar 

  41. Munoz, J. J. (1988). Action of pertussigen (pertussis toxin) on the host immune system. In Wardlaw, A. C. and Parton, R. (eds), Pathogenesis and Immunity in Pertussis, pp. 173–92. (Chichester: John Wiley & Sons)

    Google Scholar 

  42. Steinman, L., Sriram, S., Adelman, N. E., Zamuip, S., McDevitt, H. O. and Urich, H. (1982). Murine model for pertussis vaccine encephalopathy: linkage to H-2. Nature, 299, 738–40

    Article  PubMed  CAS  Google Scholar 

  43. Steinman, L., Weiss, A., Adelman, N., Lim, M., Ziniga, R., Oehlert, J., Hewlett, E., Falkow, S. (1985). Pertussis toxin is required for pertussis vaccine encephalopathy. Proc. Natl. Acad. Sci. USA, 82, 8733–6

    Article  PubMed  CAS  Google Scholar 

  44. Munoz, J. J., Peacock, M. G. and Hadlow, W. J. (1987). Anaphylaxis or so-called encephalopathy in mice sensitised to an antigen with the aid of pertussigen (pertussis toxin). Infect. Immun., 55, 1004–8

    PubMed  CAS  Google Scholar 

  45. Redhead, K., Robinson, A., Ashworth, L. A. E. and Melville-Smith, M. (1987). The activity of purified Bordetella pertussis components in murine encephalopathy. J. Biol. Stand., 15, 341–51

    Article  PubMed  CAS  Google Scholar 

  46. Black, W. J., Munoz, J. J., Peacock, M. G., Schad, P. A., Cowell, J. L., Burchall, J. J., Lim, M., Kent, A., Steinman, L. and Falkow, S. (1988). ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis. Science, 240, 656–9

    CAS  Google Scholar 

  47. Hewlett, E. L. and Gordon, V. M. (1988). Adenylate cyclase toxin of Bordetella pertussis. In Wardlaw, A. C. and Parton, R. (eds), Pathogenesis and Immunity in Pertussis, pp. 193–209. (Chichester: John Wiley & Sons)

    Google Scholar 

  48. Weiss, A. A., Hewlett, E. L., Myers, G. A. and Falkow, S. (1984). Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J. Infect. Dis., 150, 219–22

    Article  PubMed  CAS  Google Scholar 

  49. Novotny, P, Chubb, A. P., Cownley, K., Montaraz, J. A. and Beesley, J. E. (1985). Bordetella adenylate cyclase: a genus specific protective antigen and virulence factor. In Proceedings of the Fourth International Symposium on Pertussis. Dev. Biol. Stand., 61, 27–41

    Google Scholar 

  50. Brezin, C., Gujiso, N., Ladant, D., Djavadi-Ohaniance, L., Megret, F., Onyeocha, I. and Alonso, J-M. (1987). Protective effect of Bordetella pertussis adenylate cyclase antibodies against lethal respiratory infection in the mouse. FEMS Microbiol. Lett., 42, 75–80

    Article  CAS  Google Scholar 

  51. Wolff, J. and Cook, G. H. (1973). Activation of thyroid membrane adenylate cyclase by purine nucleotide. J. Biol. Chem., 248, 350–5

    PubMed  CAS  Google Scholar 

  52. Glaser, P., Ladant, D., Sezer, O, Pichot, F., Ullman, A. and Danchin, A. (1988). The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli. Molec. Microbiol., 2, 19–30

    Article  CAS  Google Scholar 

  53. Nakase, J. and Endoh, M. (1988). Heat labile toxin of Bordetella pertussis. In Wardlaw, A. C. and Parton, R. (eds), Pathogenesis and Immunity in Pertussis, pp. 211–29. (Chichester: John Wiley & Sons)

    Google Scholar 

  54. Sekiya, K. (1983). Effects of Bordetella pertussis components on IgE and IgGI responses. Microbiol. Immunol., 27, 905–15

    PubMed  CAS  Google Scholar 

  55. Rosenthal, R. S., Nogami, M., Cookson, B. T., Goldman, W. E. and Folkening, W. J. (1987). Major fragments of soluble peptidoglycan released from growing Bordetella pertussis is tracheal cytotoxin. Infect. Immun., 55, 2117–20

    PubMed  CAS  Google Scholar 

  56. Chaby, R. and Caroff, M. (1988). Lipopolysaccharides of Bordetella pertussis endotoxin. In Wardlaw, A. C. and Parton, R. (eds), Pathogenesis and Immunity in Pertussis, pp. 247–71. (Chichester: John Wiley & Sons)

    Google Scholar 

  57. Irons, L. I., Ashworth, L. A. E. and Wilton-Smith, P. (1983). Heterogeneity of the filamentous haemagglutinin of Bordetella pertussis studied with monoclonal antibodies. J. Gen. Microbiol., 129, 2769–78

    PubMed  CAS  Google Scholar 

  58. Perera, V. Y., Wardlaw, A. C. and Freer, J. H (1986). Antigenic heterogeneity in subunit S1 of pertussis toxin. J. Gen. Microbiol., 132, 553–6

    PubMed  CAS  Google Scholar 

  59. Granstrom, M., Granstrom, G., Lindfors, A. and Askelof, P. (1982). Serologic diagnosis of whooping cough by an enzyme-linked immunosorbent assay using fimbrial hemagglutinin as antigen. J. Infect. Dis., 146, 741–5

    Article  PubMed  CAS  Google Scholar 

  60. Winsnes, R., Lonnes, T., Mogster, B. and Berdal, B. P. (1985). Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough. In Proceedings of Fourth International Symposium on Pertussis. Dev. Biol Stand., 61, 353–65

    Google Scholar 

  61. Granstrom, G., Wretlind, B., Salenstedt, C-R. and Granstrom, M. (1988). Evaluation of serological assays for diagnosis of whooping cough. J. Clin. Microbiol., 26, 1818–23

    PubMed  CAS  Google Scholar 

  62. Askelof, P., Granstrom, M., Gillenius, P. and Lindberg, A. A. (1982). Purification and characterization of a fimbrial hemagglutinin from Bordetella pertussis for use in an enzyme-linked immunosorbent assay. J. Med. Microbiol., 15, 73–83

    Article  PubMed  CAS  Google Scholar 

  63. Nagel, J., de Graaf, S. and Schiif-Evers, D. (1985). Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels. In Proceedings of Fourth International Symposium on Pertussis. Dev. Biol Stand., 61, 325–30

    Google Scholar 

  64. Sato, Y. and Sato, H. (1985). Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children. In Proceedings of Fourth International Symposium on Pertussis. Dev. Biol. Stand., 61, 367–72

    Google Scholar 

  65. Pittman, M. (1985). The concept of pertussis as a toxin-mediated disease. Paediatr. Infect. Dis., 3, 467–86

    Google Scholar 

  66. Gillenius, P., Jaatmaa, E., Askelof, P., Granstrom, M. and Tiru, M. (1985) The standardisation of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells. J. Biol Standard, 13, 61–6

    Article  CAS  Google Scholar 

  67. Granstrom, M., Granstrom, G., Gillenius, P. and Askelof, P. (1985). Neutralizing antibodies to pertussis toxin in whooping cough J. Infect. Dis., 151, 646–9

    Article  PubMed  CAS  Google Scholar 

  68. Manclark, C. R. and Meade, B. D. (1980). Serological response to Bordetella pertussis. In Rose, N. R. and Friedman, N. (eds), Manual of Clinical Immunology, pp. 497–9. (Washington, DC: American Society for Microbiology)

    Google Scholar 

  69. Miller, J. J. Jr and Silverberg, R. J. (1939). The agglutinative reaction in relation to pertussis and to prophylactic vaccination against pertussis with description of a new technic. J. Immunol., 37, 207–21

    Google Scholar 

  70. Winter, J. L. (1953). Development of antibodies in children convalescent from whooping cough. Proc. Soc. Exp. Biol Med., 83, 866–70

    PubMed  CAS  Google Scholar 

  71. Macauley, M. E. (1979). The serological diagnosis of whooping cough. J Hyg. Camb., 83, 95–102

    Article  Google Scholar 

  72. Dolby, J. and Stephens, S. (1973). Pertussis antibodies in the sera of children exposed to Bordetella pertussis by vaccination or infection. J. Hyg. Camb., 71, 193–207

    Article  PubMed  CAS  Google Scholar 

  73. Preston, N. W., Mackay, R. I., Bamford, F. N., Crofts, J. E. and Burland, W. L. (1974). Pertussis agglutinins in vaccinated children: better response with adjuvant. J. Hyg. Camb., 73, 119–25

    Article  PubMed  CAS  Google Scholar 

  74. Bienenstock, J. (1986). Immunity in the gastrointestinal and respiratory tracts. In Tagliabue, A., Rappuoli, R. and Piazzi, S. E. (eds), Bacterial Vaccines and Local Immunity. Ann. Sclavo. III, 1–2, 77–86

    Google Scholar 

  75. Linnemann, C. C. Jr (1979). Host-parasite interactions in pertussis. In Manclark, C. R. and Hill, J. C. (eds), International Symposium on Pertussis, pp. 3–18. (USDHEW Publication No. (NIH) 79–1830, Washington, DC)

    Google Scholar 

  76. Goodman, Y. E., Wort, A. J. and Jackson, F. L. (1981). Enzyme-linked immunosorbent assay for detection of pertussis immunoglobulin A in nasopharyngeal secretions as an indicator of recent infection. J. Clin. Microbiol., 13, 286–92

    PubMed  CAS  Google Scholar 

  77. Ashworth, L. A. E., Day, A., Lambert, H. P., Lingham, S., Lissauer, T., Miller, E., Robinson, A., Rutter, D. A. and Thomas, M. G. (1986). Local and systemic immune responses to pertussis infection and cellular and acellular vaccines. In Tagliabue, A., Rappuoli, R. and Piazzi, S. E. (eds), Bacterial Vaccines and Local Immunity. Ann. Sclavo. III, 1–2, 199–211

    Google Scholar 

  78. Granstrom, G., Askelof, P. and Granstrom, M. (1988). Specific immunoglobulin A to Bordetella pertussis antigens in mucosal secretion for rapid diagnosis of whooping cough. J. Clin. Microbiol., 26, 869–74

    PubMed  CAS  Google Scholar 

  79. Ashworth, L. A. E., Fitzgeorge, R. B., Irons, L. I., Morgan, C. P. and Robinson, A. (1982). Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels. J. Hyg. Camb., 88, 475–86

    Article  PubMed  CAS  Google Scholar 

  80. Thomas, G. (1975). Respiratory and humoral immune response to aerosol and intramuscular pertussis vaccine. J. Hyg. Camb., 74, 233–7

    Article  PubMed  CAS  Google Scholar 

  81. Baumann, E., Binder, B. R., Falk, W., Huber, E. G., Kurz, R. and Rosanelli, K. (1984). Development and clinical use of an oral heat-inactivated whole cell pertussis vaccine. In Proceedings of Fourth International Symposium on Pertussis. Dev. Biol. Stand., 61, 511–16

    Google Scholar 

  82. Sato, Y., Kimura, M. and Fukumi, H. (1984). Development of a pertussis component vaccine in Japan. Lancet, 1, 122–6

    Article  PubMed  CAS  Google Scholar 

  83. Shukuda, Y. (1986). Manufacturing methods for the Japanese acellular vaccines. In Workshop on Acellular Pertussis Vaccines, sponsored by the Interagency Group to Monitor Vaccine Development, Production and Usage, US Department of Health and Human Services and US Public Health Service, Bethesda, September, pp. 23–6

    Google Scholar 

  84. Aoyama, T., Murase, Y., Kato, T. and Iwata, T. (1985). Efficacy of an acellular pertussis vaccine in Japan. J. Paediatr., 107, 180–2

    Article  CAS  Google Scholar 

  85. Isomura, S. (1986). Efficacy and adverse reactions associated with acellular pertussis vaccines in Japan. In Workshop on Acellular Pertussis Vaccines, sponsored by the Interagency Group to Monitor Vaccine Development, Production and Usage, US Department of Health and Human Services and US Public Health Service, Bethesda, September, pp. 47–50

    Google Scholar 

  86. Kimura, M. and Hikino, N. (1985). Results with a new DTP vaccine in Japan. In Proceedings of Fourth International Symposium on Pertussis. Dev. Biol. Stand., 61, 511–16

    Google Scholar 

  87. Isomura, S., Suzuki, S. and Sato, Y. (1985). Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamilial exposure to pertussis patients. In Proceedings of Fourth International Symposium on Pertussis. Dev. Biol. Stand., 61, 531–7

    Google Scholar 

  88. Aoyama, T., Murase, Y., Gonda, T. and Iwata, T. (1988). Type-specific efficacy of acellular pertussis vaccine. Am. J. Dis. Child., 142, 40–2

    PubMed  CAS  Google Scholar 

  89. Noble, G. R., Bernier, R. H., Esber, E. C., Hardegree, M. C., Hinman, A. R., Klein, D. and Saah, A. J. (1987). Acellular and whole-cell pertussis vaccines in Japan: report of a visit by US Scientists. J. Am. Med. Assoc., 257, 1351–2

    Article  CAS  Google Scholar 

  90. Aoyama, T. (1986). Case contact studies of efficacy with the acellular pertussis vaccines in Japan. In Workshop on Acellular Pertussis Vaccines, sponsored by the Interagency Group to Monitor Vaccine Development, Production and Usage, US Department of Health and Human Services and US Public Health Service, Bethesda, September, pp. 50–3

    Google Scholar 

  91. Anderson, E. L., Belshe, R. B. and Bertram, J. (1988). Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants. J. Infect. Dis., 157, 731–6

    Article  PubMed  CAS  Google Scholar 

  92. Railings, L. O., Olin, P. and Storsaeter, J. et al. (1988). Placebo-controlled trial of two acellular pertussis vaccines in Sweden - protective efficacy and adverse events. Lancet, 1, 955–60

    Google Scholar 

  93. Blackwelder, W. C. (1986). Design of clinical trials to demonstrate efficacy with the acellular pertussis vaccines. In Workshop on Acellular Pertussis Vaccines, sponsored by the Interagency Group to Monitor Vaccine Development, Production and Usage, US Department of Health and Human Services and US Public Health Service, Bethesda, September, pp. 81–5

    Google Scholar 

  94. Bernier, R. H., Onorato, I. A. and Romanus, V. (1986). The design of an efficacy trial of acellular pertussis vaccine in Sweden. In Workshop on Acellular Pertussis Vaccines, sponsored by the Interagency Group to Monitor Vaccine Development, Production and Usage, US Department of Health and Human Services and US Public Health Service, Bethesda, September, pp. 85–9

    Google Scholar 

  95. Rutter, D. A., Ashworth, L. A. E., Day, A., Funnell, S., Lovell, F. and Robinson, A (1988). Trial of a new acellular pertussis vaccine in healthy adult volunteers. Vaccine, 6, 29–32

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. L. A. E. Ashworth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Robinson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Microbiology, London School of Hygiene and Tropical Medicine, University of London, London, UK

    A. J. Zuckerman

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Ashworth, L.A.E., Robinson, A. (1989). Pertussis vaccines. In: Zuckerman, A.J. (eds) Recent Developments in Prophylactic Immunization. Immunology and Medicine, vol 12. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1067-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1067-6_1

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6969-4

  • Online ISBN: 978-94-009-1067-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation